A Tucson clinic is part of the clinical trial for Regeneron's monoclonal antibody cocktail, the drug used to treat President Donald Trump after his positive COVID-19 diagnosis.
A Tucson clinic is part of the clinical trial for Regeneron's monoclonal antibody cocktail, the drug used to treat President Donald Trump after his positive COVID-19 diagnosis.
State health Officer Dr. Thomas Dobbs says hospitals are preparing for an increase in COVID-19 patients.